McCourt Marion
Reporting owner on Forms 3, 4 and 5, CIK 1663758.
McCourt Marion reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, INC.CIK 872589 | officer (EVP Commercial) | 2 | 2026-11-18 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -44 | $952.79 | 10,827 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -59 | $954.46 | 10,768 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -30 | $955.51 | 10,738 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -22 | $956.01 | 10,716 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -44 | $958.47 | 10,672 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -66 | $959.46 | 10,606 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -49 | $960.31 | 10,557 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -59 | $961.36 | 10,498 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -41 | $962.44 | 10,457 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -42 | $963.7 | 10,415 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -21 | $964.69 | 10,394 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -63 | $965.62 | 10,331 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -26 | $971.93 | 10,305 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 219 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-30 | S sold | -1,132 | $869.43 | 10,871 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 219 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001663758-26-000006 | REGENERON PHARMACEUTICALS, INC. | 2026-11-18 | ||
| Form 4 0001663758-26-000004 | REGENERON PHARMACEUTICALS, INC. | 2026-11-03 |